ETV6 and acute lymphoblastic leukemia: Germline ETV6 variations are the basis for a novel genetic syndrome associated with strong predisposition to hematologic malignancies (particularly ALL), implying potential benefit of clinical identification and subsequent surveillance of the at risk individuals.